These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 8342945)
1. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. Gillam EM; Baba T; Kim BR; Ohmori S; Guengerich FP Arch Biochem Biophys; 1993 Aug; 305(1):123-31. PubMed ID: 8342945 [TBL] [Abstract][Full Text] [Related]
2. Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity. Sandhu P; Baba T; Guengerich FP Arch Biochem Biophys; 1993 Nov; 306(2):443-50. PubMed ID: 8215449 [TBL] [Abstract][Full Text] [Related]
4. Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase. Gillam EM; Wunsch RM; Ueng YF; Shimada T; Reilly PE; Kamataki T; Guengerich FP Arch Biochem Biophys; 1997 Oct; 346(1):81-90. PubMed ID: 9328287 [TBL] [Abstract][Full Text] [Related]
5. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes. Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495 [TBL] [Abstract][Full Text] [Related]
6. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5. Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180 [TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of recombinant-expressed cytochrome P450 2C3 from Escherichia coli: 2C3 encodes the 6 beta-hydroxylase deficient form of P450 3b. Richardson TH; Hsu MH; Kronbach T; Barnes HJ; Chan G; Waterman MR; Kemper B; Johnson EF Arch Biochem Biophys; 1993 Jan; 300(1):510-6. PubMed ID: 8380971 [TBL] [Abstract][Full Text] [Related]
8. Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli. Wang H; Strobel HW Arch Biochem Biophys; 1997 Aug; 344(2):365-72. PubMed ID: 9264551 [TBL] [Abstract][Full Text] [Related]
9. Cooperativity in oxidations catalyzed by cytochrome P450 3A4. Ueng YF; Kuwabara T; Chun YJ; Guengerich FP Biochemistry; 1997 Jan; 36(2):370-81. PubMed ID: 9003190 [TBL] [Abstract][Full Text] [Related]
10. Stable expression of human cytochrome P450 3A4 in conjunction with human NADPH-cytochrome P450 oxidoreductase in V79 Chinese hamster cells. Schneider A; Schmalix WA; Siruguri V; de Groene EM; Horbach GJ; Kleingeist B; Lang D; Böcker R; Belloc C; Beaune P; Greim H; Doehmer J Arch Biochem Biophys; 1996 Aug; 332(2):295-304. PubMed ID: 8806738 [TBL] [Abstract][Full Text] [Related]
11. Construction of a human cytochrome P450 1A1: rat NADPH-cytochrome P450 reductase fusion protein cDNA and expression in Escherichia coli, purification, and catalytic properties of the enzyme in bacterial cells and after purification. Chun YJ; Shimada T; Guengerich FP Arch Biochem Biophys; 1996 Jun; 330(1):48-58. PubMed ID: 8651703 [TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of recombinant cytochrome P450TYR expressed at high levels in Escherichia coli. Halkier BA; Nielsen HL; Koch B; Møller BL Arch Biochem Biophys; 1995 Oct; 322(2):369-77. PubMed ID: 7574710 [TBL] [Abstract][Full Text] [Related]
13. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase. Dong MS; Yamazaki H; Guo Z; Guengerich FP Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680 [TBL] [Abstract][Full Text] [Related]
14. Coexpression of mammalian cytochrome P450 and reductase in Escherichia coli. Dong J; Porter TD Arch Biochem Biophys; 1996 Mar; 327(2):254-9. PubMed ID: 8619611 [TBL] [Abstract][Full Text] [Related]
15. Influence of glutathione on the catalytic activity of reconstituted cytochrome P450 3A4. Kim BR; Kim DH Biochem Biophys Res Commun; 1998 Jan; 242(1):209-12. PubMed ID: 9439637 [TBL] [Abstract][Full Text] [Related]
16. Identification of three key residues in substrate recognition site 5 of human cytochrome P450 3A4 by cassette and site-directed mutagenesis. He YA; He YQ; Szklarz GD; Halpert JR Biochemistry; 1997 Jul; 36(29):8831-9. PubMed ID: 9220969 [TBL] [Abstract][Full Text] [Related]
17. Roles of divalent metal ions in oxidations catalyzed by recombinant cytochrome P450 3A4 and replacement of NADPH--cytochrome P450 reductase with other flavoproteins, ferredoxin, and oxygen surrogates. Yamazaki H; Ueng YF; Shimada T; Guengerich FP Biochemistry; 1995 Jul; 34(26):8380-9. PubMed ID: 7599128 [TBL] [Abstract][Full Text] [Related]
18. Expression of modified human cytochrome P450 1A2 in Escherichia coli: stabilization, purification, spectral characterization, and catalytic activities of the enzyme. Sandhu P; Guo Z; Baba T; Martin MV; Tukey RH; Guengerich FP Arch Biochem Biophys; 1994 Feb; 309(1):168-77. PubMed ID: 8117105 [TBL] [Abstract][Full Text] [Related]
19. Bacterial expression and purification of the Arabidopsis NADPH-cytochrome P450 reductase ATR2. Hull AK; Celenza JL Protein Expr Purif; 2000 Apr; 18(3):310-5. PubMed ID: 10733884 [TBL] [Abstract][Full Text] [Related]
20. Human fatty acid omega-hydroxylase, CYP4A11: determination of complete genomic sequence and characterization of purified recombinant protein. Kawashima H; Naganuma T; Kusunose E; Kono T; Yasumoto R; Sugimura K; Kishimoto T Arch Biochem Biophys; 2000 Jun; 378(2):333-9. PubMed ID: 10860550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]